Posted on Leave a comment

Non-Invasive Treatments: What No One Is Talking About

Sometimes it seems like the best way to guess a person’s age is by how much medicine they take daily. This system is not perfect, as some people start medications early in life, but we all seem to accumulate pills and creams as we age. That is why it can be a relief to discover an application that can be used for multiple health disorders. 

Share it

Share on facebook
Share on twitter
Share on linkedin
Share on whatsapp
Share on email

Alexa, a 58-year-old woman from Texas, United States, has suffered from type 2 diabetes for more than 6 years. She has been taking multiple medications and treatments such as inhibitors, metformin, pain relievers and antibiotics for her diabetic foot wound. After discovering D’OXYVA, a non-invasive application that significantly helped with her pain and wound management after 5 weeks of twice-daily application, she shared that she saved so much when she started decreasing the intake of other medications and avoided a possible amputation just by using this non-invasive application.

D’OXYVA, for example, can be applied for a variety of conditions related to poor circulation. This multi-application product helps consumers save money, space, and time while simplifying everyday life.

Here are a few things about non-invasive treatments that people seem unwilling to discuss.

In layman’s terms, non-invasive treatments do not break the skin or enter beyond the surface of body openings. Invasive treatments include surgery and injections. Because the needles actually penetrate the skin, acupuncture is also considered an invasive procedure. Certain procedures may be considered minimally invasive if they do not penetrate deeply into the body or only require a small incision.

Non-invasive procedures include massage and gas delivery systems such as D’OXYVA.

By nature, an invasive procedure can be hazardous. Even under a doctor’s care, for example, minimally invasive surgical procedures carry risks (Mayo Clinic). Patients can experience unforeseen complications related to anesthesia, infections, or bleeding. While these risks are mitigated with less serious regular treatments, any invasive procedure carries the potential for infections or bleeding complications.

While you should always trust your medical professional’s advice, many non-invasive treatments can be safer. Most doctors will attempt to find the least invasive, most effective treatment.

Although the human body contains many different cells and functional systems, most of them share the same basic processes. For example, every cell in the body depends on a healthy circulation system to receive nutrients and oxygen. Therefore, when a person has circulation problems, it can manifest as a number of issues. Your doctor may be able to recommend one product like D’OXYVA for multiple circulation-related issues.

Examples of Circulation Related Issues

  • Slow-healing wounds, especially those related to diabetes or other cardiovascular issues
  • Septic shock related to a severe infection or a compromised immune system
  • Many forms of chronic pain
  • Varicose veins and other blemishes

 

HOW D’OXYVA CAN HELP?

D’OXYVA is the only fully noninvasive, completely painless over-the-skin microcirculatory and nerve stimulant solution that has been validated to significantly improve microcirculation.

The improvement of microcirculation, i.e., blood flow to the smallest blood vessels, benefits one’s health, immune system and overall sense of well-being in a variety of ways.

If you suffer from symptoms related to poor circulation, you may not need to suffer in silence.

        BUY D’OXYVA

Posted on Leave a comment

10 Common Misconceptions About Pain Management

pain reliever

Chronic pain is a worldwide phenomenon that requires different treatment approaches for different patients. A number of common misconceptions about proper pain management exist, and these can affect the efficacy of a pain management program. Read on to learn about the case of Amy B., who required a specialized pain management approach to control her chronic pain.

Share this

Share on facebook
Share on twitter
Share on linkedin
Share on whatsapp
Share on email

Amy B. was a 67-year-old female patient with severe pain from multiple fractures and osteoarthritis. She was originally prescribed Tylenol with codeine, which did not control her pain. After the addition of the non-invasive deoxyhemoglobin vasodilator D’OXYVA[1], Amy was completely pain free within 6 weeks.

Misconception #1

All Patients Complain About Their Pain Levels to Obtain Pain Medications
Although some patients who seek pain medications to feed drug addictions do “overcomplain” about their pain levels, studies have consistently shown that the vast majority of legitimate pain management patients accurately describe their pain levels using a pain scale that ranges from 1 to 10.
Misconception #2

Narcotic Pain Medications Are Always the Best Chronic Pain Treatments
Many other modalities[2] can be attempted before using narcotic pain medications. These alternatives include physical therapy, massage therapy, biofeedback, stretching and exercise. In addition researchers have found that the application of the non-invasive deoxyhemoglobin vasodilator D’OXYVA significantly decreases pain, especially in patients with diabetic neuropathy.
Misconception #3

All Pain Management Patients Should Start on NSAIDs
Depending on the patient’s pain level, other medications such as opioids may be the appropriate first choice for adequate pain control.
Misconception #4

All Pain Management Patients Are Drug Addicts Who Are Seeking Drugs
Legitimate pain management patients with conditions such as severe arthritis, gout, spinal stenosis, diabetic neuropathy, or diabetic foot ulcers are not drug addicts even though they require daily pain medications. Other types of patients with conditions such as obsessive compulsive disorder or actual drug addictions may seek to divert pain medications to feed their addictions.
Misconception #5

Treatment with Opioid Pain Medications Always Completely Eliminates a Patient’s Pain
The goal of pain management is to reduce a patient’s pain level using the lowest dose of opioids possible. This does not always result in complete pain relief. Other modalities such as the application of D’OXYVA can be used to help control chronic pain.
Looking for Misconceptions #6 - 10?
Leave your email below and we will send it straight to your email plus a surprise gift!
CLAIM GIFT NOW!
Previous
Next

HOW D’OXYVA CAN HELP?

D’OXYVA is the only fully noninvasive, completely painless over-the-skin microcirculatory and nerve stimulant solution that has been validated to significantly improve microcirculation.

The improvement of microcirculation, i.e., blood flow to the smallest blood vessels, benefits one’s health, immune system and overall sense of well-being in a variety of ways.

Posted on Leave a comment

Heart attacks during pregnancy are on the rise, study says

heart attack in pregnancy

Heart disease is known to kill nearly 420,000 women in the U.S. each year, and is the leading cause of maternal deaths. The numbers are even more staggering for African-American mothers, whose risk of dying from heart-related complications is three times higher than for white women.

“We’re seeing that there’s actually an increase in the number of heart attacks during pregnancy, and that number is going up in the United States,” Lenox Hill Hospital cardiologist Dr. Catherine Weinberg told CBS News’ Dr. Tara Narula. “We don’t exactly understand why. We also sometimes unmask disorders that we didn’t realize were present before.”

Share this post:

Share on facebook
Share on google
Share on twitter
Share on linkedin
Share on whatsapp
Share on email

A recent study found that about one in four pregnancy or postpartum deaths are caused by cardiovascular complications – hypertensive disorders in particular affect as many as one in 10 women and cause increased risk of heart failure, heart attack, and stroke.

First-time mother Michelle Emebo experienced the dangers firsthand. In her third trimester in 2014, she was told during a routine doctor’s visit that her blood pressure was extremely high, and said the moment changed her life forever.

“When I went back the following week and my pressure was still high, that’s when I knew there was something wrong,” she said.

Emebo was soon diagnosed with gestational hypertension – high blood pressure that develops during pregnancy after 20 weeks. In severe cases, it can cause preeclampsia or eclampsia, both fatal conditions to mother and baby.

Emebo said she was clueless at the time as to what caused her hypertension, only that she gained “a lot of weight.”

Four months after giving birth, Emebo was still struggling with her blood pressure, her weight and another condition called chronic postpartum hypertension, and was prescribed a daily blood pressure pill.

Risk factors for cardiovascular disease related maternal mortality are race, ethnicity, hypertension, obesity and age over 40.  

She turned to diet and exercise as reliable methods to improve her health – she cut sodium from her diet, portion-controlled her meals and began a 5-day-per-week workout regimen. Over four years, she lost 75 pounds.

Emebo credits her daughter as motivation for getting healthy, as well as caring for her own self.

“I’m not just Sarai’s mom, I’m Michelle, too, and I have to take care of myself,” she explained. As of Winter 2019, she no longer needed blood pressure medicine.

After conquering her issue, Emebo set out to pass the warning on to other women.

“When you think of heart disease, you think of heart attack, you think of stroke,” she said, reflecting on her experience. “Hypertension is a real issue. A cardiovascular disease while pregnant is a real issue. We have to get the information out there for moms and for families.” 

HOW D’OXYVA CAN HELP?

D’OXYVA is the only fully noninvasive, completely painless over-the-skin)microcirculatory solution that has been validated to significantly improve microcirculation.

The improvement of microcirculation, i.e., blood flow to the smallest blood vessels, benefits one’s health, immune system and overall sense of well-being in a variety of ways.

Posted on Leave a comment

‘It literally came out of nowhere’: Mom, 39, warns others after suffering heart attack

Jennifer Andrews was driving on a New Jersey highway last month when she suddenly suffered a massive heart attack. As she fell unconscious behind the wheel, her car careened down an embankment and stopped in heavy brush and trees. A Good Samaritan who saw what happened and followed had to resuscitate her three times to get her heart beating normally again.

Share on facebook
Share on google
Share on twitter
Share on linkedin
Share on whatsapp
Share on email

At 39, Andrews had never experienced any heart issues or symptoms before and was “completely blindsided,” she said.

“It literally came out of nowhere,” Andrews, an executive assistant who lives in borough of Washington, New Jersey, told TODAY. “It’s extremely scary. I feel like this is something that happens to 80-year-old men.”

Andrews was even more stunned since she had just gone to her primary care doctor for her annual checkup just two weeks before the episode. All the bloodwork came back fine, as did checks of her heart rate and blood pressure, she noted. She exercised regularly and led a low-stress life.

The mother of two did have risk factors, including smoking a few cigarettes a day, being overweight and having a family history of heart disease — her father died of heart problems in his mid-50s — but said it never crossed her mind to worry about her heart at her age.

After waking up in the hospital four days after the January 9 accident, Andrews was incredulous when doctors told her she had a 100% blockage in one of her coronary arteries, requiring a stent.

“I didn’t believe them. If it wasn’t for me waking up in the hospital with the tubes in my arm and the oxygen in my nose — and I could tell I had been intubated because my throat was hurting — I would have never believed it,” she said.

Know the risk factors and symptoms

It’s possible for people to do everything right and still have heart problems sneak up on them, said Dr. Sharonne Hayes, a cardiologist and founder of the Women’s Heart Clinic at the Mayo Clinic in Rochester, Minnesota. 

February is American Heart Month, an annual campaign to raise awareness of heart disease — the leading cause of death for both men and women in the U.S., yet many people still think of it as a “man’s illness.”

The risk goes up as people age, so heart attacks in premenopausal women are not common, but they do happen, Hayes noted. A recent study found heart attacks are on the rise in women between the ages of 35 and 54.

It leads expert to wonder: Are doctors are not paying enough attention to those women’s risk factors, or is the type of heart disease younger women develop fundamentally different than heart disease in the elderly or in men? The answer is probably a combination of both those factors, Hayes said.

Her research interest is spontaneous coronary artery dissection — a tear in a coronary artery wall — which often affects women who are otherwise healthy, with few or no risk factors for heart disease, according to the American Heart Association.

Hayes advised women under 50 who have suffered a heart attack with no risk factors to talk to their doctor about whether they had a SCAD or another heart attack cause not related to plaque buildup.

Hayes didn’t treat Andrews, but said it’s understandable why she would feel blindsided. A typical 39-year-old woman may be more focused on reproductive issues or the risk of breast cancer than her heart health because she probably doesn’t have any friends and family her age who have heart disease, Hayes noted.

The key for everyone is to pay attention to risk factors — including high blood pressure, unhealthy cholesterol levels, diabetes, excess weight, smoking and a family history of heart disease — and address the ones you can control.

For example, even light smoking — like the three or four cigarettes a day Andrews smoked before her accident — is a compelling risk factor for heart disease, Hayes said.

“But even people who optimally control all the risk factors still could have a heart attack,” Hayes said.

“Recognize it could happen and know what to do if you get the symptoms or somebody around you gets the symptoms.”

Chest pain is still the No. 1 warning sign for both sexes, but women can also experience different symptoms than men, including pain in the neck, jaw, throat, abdomen or in the upper back between the shoulder blades.

Andrews did have some upper back pain in the weeks leading up to her heart attack, but said that was typical for her and the condition was being treated by a chiropractor.

Since the heart attack, Andrews has quit smoking, is watching her salt, fat and cholesterol intake and feels fine, she said. There are new medications to take and doctors to visit during her follow-up care. The accident left her with bruising from the seat belt, but she’s recovering well.

“It was very eye-opening,” Andrews said about the ordeal, noting she was indebted to everyone who saved her life.

“I feel like ‘thank you’ isn’t enough. I don’t know what to say for them to understand how grateful I am.”

HOW D’OXYVA CAN HELP?

D’OXYVA is the only fully noninvasive, completely painless over-the-skin microcirculatory solution that has been validated to significantly improve microcirculation.

Taking D’OXYVA® daily promotes benefits related to significantly improved blood circulation, including significantly increased cardiac activity, physical fitness, metabolism, endurance, energy balance and a healthy weight.

Posted on Leave a comment

A Shocking Simple Solution to Improve the Appearance of Fine Lines and Wrinkles

The appearance of fine lines and wrinkles can affect both self-esteem and skin health. Many treatments exist to help eliminate facial lines and wrinkles and to improve overall facial aesthetics. The following is a case involving Aretha, who was a 72-year-old female patient with severe, deep lines, loose skin, and wrinkles on her face.

Share It

Share on facebook
Share on whatsapp
Share on twitter
Share on linkedin
Share on email

Aretha worked as a realtor before retiring, and she enjoyed playing golf and going to the beach.

As a teenager and young adult, Aretha often spent hours tanning in the sun.

She also frequented tanning salons in her hometown.

Aretha expressed a desire to have a more youthful appearance of her face and neck.

Her past medical history was significant for type 2 diabetes mellitus, which was well controlled on oral medications, as well as well-controlled high blood pressure.

She also had a history of smoking one pack of cigarettes per day since she was 15.

Aretha presented with very lax skin on her face and neck.

She also had deep creases around her mouth and nose with excess fat and skin under her chin.

After a 2-week twice a day D’OXYVA[1] application for 5 days a week, a 2-week application once a day for 5 days a week, and a final 2-week application once a day for 3 days a week, Aretha had the following results:

  • Tightening of her loose and sagging facial skin
  • Reduction of drooping cheeks around her jawline
  • Decreased drooping of the corners of her mouth
  • Reduction of creases between her cheeks and lips
  • Reduction of fine lines around her eyes and lips
Structure of the Skin

The skin[2] and its structures are known as the integumentary system.

The top layer of the skin is called the epidermis, and it is composed of keratinized squamous epithelial cells.

This layer has a protective function, is impervious to water and contains no blood vessels.

The next layer of the skin is called the dermis, and it contains blood vessels, nerves, hair follicles and sweat glands.

The hypodermis is the layer below the dermis, and it contains fat cells that are highly vascularized.

Microcirculation of the Skin

Microcirculation refers to the smallest blood vessels in the body.

This includes the arterioles, the venules and the capillaries.

The skin’s microcirculation[3] (also known as cutaneous microcirculation) consists of 2 horizontal vascular plexuses.

The first vascular horizontal microcirculation plexus is located approximately 1 to 1.5 mm below the skin’s surface.

The second vascular horizontal microcirculation plexus is located at the junction of the dermis and the hypodermis.

Ascending arterioles and descending venules are paired together and connect these two plexuses.

The dermal venules remove waste products from the skin.

The dermal arterioles supply oxygen and nutrients to the skin.

Most of the skin’s microcirculation is located 1 to 2 mm under its surface.

D’OXYVA Application to Improve the Microcirculation of the Skin

D’OXYVA is a noninvasive over-the-skin deoxyhemoglobin vasodilator that delivers a vapor of pharmaceutical-grade CO2 and water to the peripheral microcirculation.

This vapor is delivered through the placement of the D’OXYVA device over the thumb for a 5-minute period.

The CO2 then travels into the microcirculation of the skin, where it causes a vasodilation that leads to increased perfusion.

This then improves oxygenation and removal of toxins from the skin, which improves both the health of the skin and its general appearance.

Conclusion

The appearance of fine lines and wrinkles can affect self-esteem and skin health. D’OXYVA application can improve sagging skin and wrinkles without the risks associated with more invasive surgical treatments such as face-lifts.

HOW D’OXYVA CAN HELP?

D’OXYVA is the only fully noninvasive, completely painless over-the-skin microcirculatory solution that has been validated to significantly improve microcirculation.

The improvement of microcirculation, i.e., blood flow to the smallest blood vessels, benefits one’s health, immune system and overall sense of well-being in a variety of ways.

Posted on Leave a comment

Women’s blood vessels age faster than men’s: Study

New research shows for the first time that women’s blood vessels, both large and small arteries, age at a faster rate than men’s.

The findings, published Wednesday in JAMA Cardiology, challenge the long-held belief that vascular disease and cardiovascular risk in women lags behind men by up to 20 years, concluding that certain vascular changes in women actually develop earlier and progress faster in women compared to men.

Share It

Share on facebook
Share on whatsapp
Share on twitter
Share on linkedin
Share on email

“We were inspired to take a much closer look at blood pressure trajectories over the life course in women compared to men because, at the end of the day, the vast majority of cardiovascular disease processes tend to start with blood pressure elevation as a major driving risk factor,” said Dr. Susan Cheng, director of public health research at the Smidt Heart Institute at the Cedars-Sinai Medical Center in Los Angeles, and senior author on the study.

The study looked at nearly 145,000 blood pressure measurements from more than 32,000 people, ranging in age from 5 to 98, over the course of four decades.

Researchers found that blood pressure started increasing in women as early as 30, and continued to rise higher than blood pressure in men throughout the women’s life span.

“Our findings suggest that all the ways by which we think about and aim to prevent or treat high blood pressure likely needs to be more tailored, for women,” Cheng said.

One of the reasons Goldberg, who was not involved in the study, cited for patients not taking their blood pressure medications is that people stop taking them if their blood pressure improves. Treating blood pressure is not like treating a pneumonia or cough, patients must continue to take blood pressure medication for them to be effective.

“We need to be more vigilant, because when high blood pressure is treated it is a way of preventing other diseases, like stroke, heart attacks and heart failure,” Goldberg said.

Dr. Manavjeet Sidhu, MD, MBA, is a chief resident physician in emergency medicine and contributor to the ABC News Medical Unit.

HOW D’OXYVA CAN HELP?

D’OXYVA is the only fully noninvasive, completely painless transdermal (over-the-skin) microcirculatory solution that has been clinically tested to significantly improve microcirculation.

The improvement of microcirculation, i.e., blood flow to the smallest blood vessels, benefits one’s health, immune system and overall sense of well-being in a variety of ways.

Posted on Leave a comment

D’OXYVA® improves dermal microcirculation and promotes wound healing in the diabetic foot (clinical trial update)

Prof. Puruhito and colleagues have released the results of three observational trials showing that D’OXYVA® (Circularity Healthcare LLC), a deoxyhemoglobin vasodilator, improves vasodilation in the treatment of diabetic foot ulcers (DFUs), boosts dermal microcirculation, and helps in the healing process of DFUs.

Share It

Share on facebook
Share on whatsapp
Share on twitter
Share on linkedin
Share on email

Published in PRWeb

D’OXYVA® is a validated circulatory and nerve stimulant. The system was used by Prof. Puruhito for CO2 transdermal delivery, which has been shown to produce higher oxygen unloading by hemoglobin, thereby increasing oxygen-rich blood flow in the local microcirculatory system1. This improved dermal microcirculation leads, in turn, to enhanced wound healing2.

The American Diabetes Association standards of care for DFUs refer to microvascular complications and their treatment via improvements in microcirculation; therefore, Prof. Puruhito’s team set out to test CO2 transdermal delivery via D’OXYVA® in their patients. They have been gathering data since 2015, which led to the following results.

During the course of a 5-day treatment, O2 saturation increased in patients treated with transdermal CO2 in comparison to controls (15 patients/group)3 over the whole measurement range (up to 120 minutes post application). Moreover, a consistent heart rate decrease was found in patients undergoing transdermal CO2 treatment. Furthermore, the perfusion index (PI) showed an upwards tendency in the treatment group, whereas it remained stable for untreated controls. See figure 1.

diabetic wound

Figure 1: Changes observed after a 5-day transdermal CO2 treatment with D’OXYVA®. H1-H5: pre-treatment, 10, 30, 60, 90, and 120 minutes after; blue trace: control, orange trace: treatment. (A) Changes in O2 saturation (B) Decrease in heart rate due to treatment (C) Masimo® measurements of PI.

In light of these results, Prof. Puruhito’s team performed extra measurements of transcutaneous carbon dioxide (TcPCO2), O2 saturation, and PI in the 15 patients treated with D’OXYVA® for transdermal CO2 delivery3–5. This data show that the oxygen saturation reached almost 100% in some patients, whereas the TcPCO2 remained relatively stable throughout the treatment time (120 minutes). For more detailed information, see figure 2.

Figure 2: Transcutaneous CO2 pressure (TcPCO2), O2 saturation, and PI assessment in the 15 patients subjected to transdermal CO2. (A) SENTEC TcPCO2 measurements for all patients at various time points after D’OXYVA® application (pre-treatment, 5, 60, 90, and 120 minutes after) (B) O2 saturation (C) PI.

Finally, Prof. Puruhito’s team demonstrated the positive effects of transdermal CO2 delivery via D’OXYVA® on the healing of DFUs5 (fig. 3), proving the clinical potential of this intervention to improve the quality of life of people suffering from this common complication of diabetes.

Figure 3 Wound healing after 5-day treatment with transdermal CO2 delivery via D’OXYVA® in cases of DFU Wagner-1 and Wagner-2

In conclusion, the use of a D’OXYVA® device for transdermal CO2 delivery improves the outcomes of DFUs by enhancing dermal microcirculation and increasing perfusion rates and tissue oxygenation, therefore assisting in the healing process of the ulcers typical of diabetes neuropathy.

ABOUT PROF. ITO PURUHITO

Ito Puruhito, MD is professor in the Department of Thoracic and Cardiovascular Surgery at Dr. Soetomo General Hospital as well as a senior lecturer in the Faculty of Medicine at Universitas Airlangga (Indonesia). From 2001 to 2016, he was the rector of the aforementioned university. Prof. Puruhito finished his medicine studies at Universitas Airlangga in 1967, and in 1972 he received a doctorate degree, graduating cum laude from Frederich-Alexander University (Erlangen-Nürnberg, Germany). In his native country, he developed the Department of Thoracic-Cardiovascular Surgery at his former university, Universitas Airlangga, Surabaya. In 1978, he co-founded the Indonesian Association of Thoracic, Cardiac and Vascular Surgery. Prof. Puruhito has authored numerous indexed research articles in Scopus, ISI-Thompson or PUBMED, and scientific presentations and written several books in Indonesian, English, and German. He acted as reviewer for peer-reviewed journals such as Medical Tribune, Annals of Thoracic and Cardiovascular Surgery, Asian Annals of Surgery, Medicinus, and many more Indonesian medical-surgical journals. Currently, apart from lecturing, Prof. Puruhito actively researches stem cells, cardiovascular medicine, and surgery at the Institute of Tropical Disease as well as some work in microcirculation. Further, he acts as coordinator of research affairs at the Department of TCV-Surgery at Dr. Soetomo General Hospital Surabaya. Since 2014, he has been the chairman of the Council of Research in the Ministry of Research Technology and Higher Education of the Republic of Indonesia.

ABOUT D’OXYVA

D’OXYVA® (deoxyhemoglobin vasodilator) is a novel, clinically validated blood flow and nerve stimulant for people suffering from neuropathy. In various clinical trials, D’OXYVA® has validated leading independent research results and demonstrated above-average results in improving a host of physiological functions.

Subjects suffering from high blood sugar have reported neuropathy pain relief minutes after D’OXYVA® was administered and long-term blood sugar level improvements after just a few weeks.

Rapid and gentle skin delivery (over-the-skin) with the D’OXYVA® lightweight, handheld device has prompted improvements in blood microcirculation or PI by 33%* on average in all participants. Lasting results have been measured at 5-60 minutes and up to 4 hours after a single 5-minute D’OXYVA® delivery on the skin surface without reduction in PI levels.6

Posted on Leave a comment

Fibromyalgia and Microcirculation: What Fibro Patients Need To Know

If you’ve been diagnosed with fibromyalgia, you know how debilitating the disease’s widespread nerve pain can be to your body. New research shows that microcirculation problems may be among the causes of fibro nerve pain. 

Share It

Share on facebook
Share on twitter
Share on linkedin
Share on email

The concept of microcirculation—the circulation of blood in your body’s smallest blood vessels—may be a key to unlocking the mysteries of fibromyalgia. 

The Latest Research on Microcirculation and Fibromyalgia

As more patients are diagnosed with fibromyalgia each year, research on the disease’s causes and potential treatments are increasing rapidly. A study was done on exactly how blood circulates near tender points in the body in fibromyalgia patients. Circulation was found to be poor near tender points, leading researchers to believe that microcirculation near the surface of the skin is at play when it comes to fibromyalgia pain.

Many people who have been diagnosed with fibromyalgia find that it’s harder to exercise than it was before they began experiencing fibromyalgia symptoms. Studies have shown that microcirculation problems can contribute to exercise intolerance and muscular fatigue in fibromyalgia patients. Although exercise has been shown to help with fibromyalgia symptoms, it can be hard to use movement as an effective treatment when it can also lead to painful flare-ups. This can be disheartening for fibro patients who are trying their best to manage their stress and symptoms through exercise. 

Improving Microcirculation in Fibromyalgia Patients

If you think some of your fibromyalgia symptoms may be related to microcirculation problems, you’re not alone. Many fibro patients are finding that improving microcirculation relieves some of their fibro symptoms. Let’s take a look at some of the options for improving microcirculation: 

  • Exercise – As stated above, exercise can be a great way to get the blood moving and improve microcirculation. However, many fibro patients find that they need to experience symptom relief before they feel well enough to exercise. 
  • Heat therapy – Spending time in a sauna or hot tub or using a heating pad can get your blood flowing directly beneath the skin. Although this is a short-term solution, it can provide relief to people who need assistance with microcirculation. 
  • D’OXYVA – A fairly new innovation in the world of microcirculation, D’OXYVA is a transdermal delivery application that significantly improve microcirculation, with validated results to give relief from pain to patients who need it most and are unable to get help with microcirculation through exercise. Most fibromyalgia patients find that they achieve significant pain relief after using D’OXYVA for 2-7 days. 

If you suffer from fibromyalgia, you’re not alone. Help is available. Using a combination of exercise, heat therapy, and D’OXYVA may give you the relief you’re looking for. 

HOW D’OXYVA CAN HELP?

D’OXYVA is the only fully noninvasive, completely painless over-the-skin microcirculatory solution that has been validated to significantly improve microcirculation.

The improvement of microcirculation, i.e., blood flow to the smallest blood vessels, benefits one’s health, immune system and overall sense of well-being in a variety of ways.

Posted on Leave a comment

Improving Microcirculation for Weight Reduction in Obesity

weight loss obesity

Obesity, by definition, is a Body Mass Index (BMI) of 30 kg per square meter or greater. The prevalence of obesity has increased and is now thought to affect more than one third of the adult population.[1] Recent studies have shown that obesity has an adverse effect on microcirculation and is an important risk factor for the development of many health problems, such as metabolic syndrome (insulin resistance, elevated lipid levels, high blood pressure and increased abdominal girth), ischemic heart disease, heart failure, and other cardiovascular diseases.[2] The following case demonstrates how improving microcirculation can help with weight reduction in obese patients.

Brenda V was a 39-year-old white female patient with severe obesity and a BMI of 52.4 kilograms per square meter.

Brenda’s past medical history was significant because it incuded a history of morbid obesity, high cholesterol, high blood pressure, diabetes mellitus, gout, and depression.

She revealed that she could only walk for one block without severe shortness of breath and had to sleep on 2 pillows at night.

On physical examination, her weight was 340 pounds, and her height was 5 feet, 1 inch.

Her blood pressure was 180/105, and her cardiovascular exam revealed severe pitting edema of both legs.

Brenda’s abdomen was distended and morbidly obese with decreased bowel sounds.

Her laboratory exam showed a hemoglobin A1C level of 12.5% (normal is less than 5.7%) and a triglyceride level of 600 mg/dl (normal is less than 150 mg/dl).

Brenda was put on a regimen of diet, increased exercise, and the use of the peripheral deoxyhemoglobin vasodilator D’OXYVA[3] for 5 minutes per day, 5 times a week, for a 3 month period.

After this treatment she had the following improvements:

  • Increased physical activity
  • Decreased blood sugar levels
  • Decreased blood pressure
  • Decreased triglyceride levels
  • Decreased HgbA1C levels
  • Increased cardiac function
  • Increased endurance
  • Increased physical fitness
  • Decreased depression
  • Massively decreased weight
  • Increased mobility

      BUY D’OXYVA

How Does Obesity Affect Microcirculation?

Microcirculation[4] refers to the body’s smallest branching blood vessels (arterioles, venules, and capillaries with internal diameters less than 100 microns) that supply oxygen to and remove wastes products from the body’s tissues.

Microcirculation responds to changes in metabolic demands or sympathetic nervous system activation by either expanding or contracting to increase or decrease perfusion levels.

Early in the course of obesity, dysfunctional changes begin to appear in microcirculatory endothelial lining cells”.

These changes are caused by oxidative stress and inflammation of the microcirculation[5] and are now thought to lead to both insulin resistance and hypertension.

Conclusion

Obesity has been found to lead to microcirculatory dysfunction, which causes severe health problems, such as metabolic syndrome, diabetes mellitus and various cardiovascular diseases. Reducing obesity through a program of strict dietary control, increased exercise and the use of D’OXYVA to enhance microcirculation can significantly improve general health and reduce the risk of potentially lethal health complications.

      BUY D’OXYVA

HOW D’OXYVA CAN HELP?

D’OXYVA is the only fully noninvasive, completely painless over-the-skin microcirculatory solution that has been validated to significantly improve microcirculation.

The improvement of microcirculation, i.e., blood flow to the smallest blood vessels, benefits one’s health, immune system and overall sense of well-being in a variety of ways.

Posted on Leave a comment

Innovative Collaboration: The Cutting Edge of Medicine Goes “Behind The Scenes”

LOS ANGELES (PRWEB) DECEMBER 11, 2019

Circularity is partnering with Telly Award-Winning “Behind the Scenes” to provide regular, ongoing, high-quality content from leading experts in a variety of fields with an initial focus on microcirculation science, regenerative medicine, and advanced wound healing and related symptoms. The show reaches 60 million households domestically.

“Behind The Scenes with Host Laurence Fishburne” is a public television icon that has won numerous awards and delivers precision idea-telling at its best. Circularity is an innovative healthcare organization that is health-bent on their trademarked slogan: “Improving Lives by Improving Blood Flow.” Their coming together to bring forward the ideas of modern health science on a stellar entertainment platform can only make for riveting content going forward. Viewers will find themselves in a win-win situation.

Watching informative content via this stylized venue will leave viewers feeling quite satisfied with their television watching experience. It is time well spent and information precisely delivered.

A Little More About Circularity

Circularity is concerned with bringing the very best in healthcare innovation to the public. In so doing, they have manufactured a product called D’OXYVA. This product has a two-pronged approach to health. First, it can be quite effective in reducing the debilitative effects of many of the diseases that are affecting the world today, such as COPD, diabetes, and cardiovascular illnesses. Secondly, Circularity’s D’OXYVA can be used in a preventative capacity to improve microcirculation. The concept of microcirculation has far-reaching implications in neurology, oncology, endocrinology, cardiovascular health, respiratory health, dermatology, diabetic wound healing or diabetic wound care and other major fields.

What “Behind The Scenes with Host Laurence Fishburne” Will Bring to the Table

Behind The Scenes has been an innovator in bringing information to the forefront in the public television space. The award-winning series features segments on the newest technologies, as well as fresh takes on existing entities, phenomenon, and natural occurrences. The show’s website boasts that the television series “highlights the evolution of education, medicine, science, technology and industry through inspiring stories.”

Aside from the Emmy-winning and Academy Award nominated actor Lawrence Fishburne as host, the program has an award-winning creative development team. Viewers walk away with a rich knowledge of the subject. Viewers may have known about this subject their whole lives, or it may be about something completely new. Viewers learn an evolving aspect of the topic which keeps the perspective fresh.

The dawning of a new age has appeared with this collaboration. Individuals who want to know more about what the health science field is bringing into our hospitals and doctors’ offices will not be disappointed. In today’s world, it is imperative that we are advocates for our own health.

Coming Soon: Miami ReLife’s Dr. Steven Gelbard

The first series is with Dr. Steven Gelbard, a nationally-famed authority with his ReLife Miami Institute on stem cells. Dr. Gelbard presents D’OXYVA’s Nobel Prize-winning science as a regenerative medicine. Dr. Gelbard is involving his direct contacts with top NFL players and other top sports celebrities in the monthly series, along with 25—40 top neurosurgeons and other experts working under ReLife.

Imagine having the ability to receive D’OXYVA and other innovative treatments and non-invasive procedures for chronic wound care amid the luxury of a five-star hotel. Behind The Scenes guest, Dr. Gelbard, a Tufts School of Medicine educated neurosurgeon, makes it happen right now. Medicine has left the hospital building and has become the proactive choice of the health conscious. We can all look forward to learning more about how to live a healthier and more informed lifestyle from this awe-inspiring episode.

According to Norbert Kiss, President and CEO of Circularity Healthcare, this collaboration is door busting. Mr. Kiss tells us, ”[We] can offer unprecedented access to this amazing Emmy-winning show called Behind the Scenes with very amazing terms due to our strategic involvement. We welcome any expert.”

Laurence Fishburne, host of Behind The Scenes,” beckons, “Join me as we all discover the endless ways to enjoy the skills and imagination.”

Don’t miss the evolution. It’s being televised. Circularity and Behind The Scenes—Stay tuned for a mind-fortifying experience!

Circularity Values:

We, at Circularity believe in a long-sought-after goal in health care; people should have access to one health application that solves most of their short and long term health issues without compromising other aspects of their health while doing this quickly, affordably, and without pain.
Circularity develops, manufactures and markets advanced technologies that significantly improve quality of life by improving some of the most essential physiological functions in the body.

About Behind The Scenes With Laurence Fishburne

Behind The Scenes is an award-winning program that highlights new stories and innovative concepts through groundbreaking short-form and long-form documentary presentation. The program, which is anchored by a veteran production team with decades of industry experience, is able to effectively communicate the most critical stories to a wide and diverse audience.

Behind The Scenes with Laurence Fishburne, has established an impressive and heralded career, amassing over one-hundred credits across the varied platforms of stage, television and film. He’s well known for major for roles in such films as; John Wick 2, Fantastic 4 Rise of the Silver Surfer, Mission Impossible III, Mystic River, Boyz n the Hood, What’s Love Got to Do With It, and Apocalypse Now. On the small screen, the award-winning and versatile actor played compelling roles in shows such as CSI: Crime Scene Investigation, CSI: Miami, CSI: New York and Hannibal. The Behind The Scenes Actor currently stars as Pops on the hit TV comedy Black-ish.

About Circularity Healthcare, LLC

Circularity Healthcare, LLC, located in Los Angeles, CA is a private biotech and medtech products and services company that designs, makes, markets, sells, distributes and licenses its own patented and patent pending technologies, such as its flagship non-invasive deoxyhemoglobin vasodilator product line, D’OXYVA®. One of the main mechanisms underlying D’OXYVA’s science received the Nobel Prize for Medicine in 2019. Circularity enters into exclusive agreements with manufacturers to launch products and with large and small clinics and hospitals in order to help them enhance their profits and credit profiles with a wide variety of advanced products and services. In addition, Circularity Healthcare assists in the financing of equipment, working capital and also patient financing at industry-leading terms and speed.